1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one - CAS 13877-55-9
Catalog: |
BB008833 |
Product Name: |
1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one |
CAS: |
13877-55-9 |
Synonyms: |
1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one |
IUPAC Name: | 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one |
Description: | 1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one (CAS# 13877-55-9) is a useful research chemical. |
Molecular Weight: | 136.114 |
Molecular Formula: | C5H4N4O |
Canonical SMILES: | C1=NNC2=C1N=CNC2=O |
InChI: | InChI=1S/C5H4N4O/c10-5-4-3(1-8-9-4)6-2-7-5/h1-2H,(H,8,9)(H,6,7,10) |
InChI Key: | JFZSDNLQDTYVEE-UHFFFAOYSA-N |
Boiling Point: | 463.5 °C at 760 mmHg |
Density: | 1.89 g/cm3 |
MDL: | MFCD08234378 |
LogP: | 0.05850 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021094830-A2 | Nitrogen oxide-donating pde-5 and/or pde-6 inhibitor compounds | 20191111 |
KR-20210106508-A | DNA polymerase IIIC inhibitors and uses thereof | 20181221 |
CA-3074865-A1 | Methods of detection using x-ray fluorescence | 20170914 |
WO-2019055754-A1 | DETECTION METHODS USING X FLUORESCENCE | 20170914 |
EP-3681504-A1 | Methods of detection using x-ray fluorescence | 20170914 |
PMID | Publication Date | Title | Journal |
17894860 | 20070925 | Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase | BMC structural biology |
18066912 | 20070101 | Interactions of calf spleen purine nucleoside phosphorylase with formycin B and its aglycone - spectroscopic and kinetic studies | Nucleosides, nucleotides & nucleic acids |
16870435 | 20061001 | Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa | Bioorganic & medicinal chemistry letters |
16682200 | 20060715 | Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa | Bioorganic & medicinal chemistry letters |
16263283 | 20060201 | New bicyclic cannabinoid receptor-1 (CB1-R) antagonists | Bioorganic & medicinal chemistry letters |
Complexity: | 190 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 136.03851076 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 136.03851076 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 70.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyrazolo[n,m-d]Pyrimidine
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS